Thermo Fisher Dips -2.11% as Investors Await Q4 Earnings
$Thermo Fisher Scientific(TMO)$
Thermo Fisher Scientific Inc. (TMO) Consolidates Near Highs: Eyes $653 Target Post-Earnings 📊
Latest Close Data 📅
Closed at $625.98 on 2026-01-26 (ET), down -2.11% from the previous close. The stock is trading -2.8% below its 52-week high of $643.99.
Core Market Drivers 🚀
-
Earnings on the Horizon: The company is scheduled to report Q4 2025 earnings on Jan 29, 2026. Market consensus expects revenue of $11.95B (+5.96% YoY) and adjusted EPS of $6.45 (+8.53% YoY).
-
Strategic AI Partnership: Recent collaboration with NVIDIA to build autonomous lab infrastructure could be a long-term growth catalyst, enhancing R&D efficiency in biopharma.
Technical Analysis 📈
-
Volume: Trading volume of 2.85M shares was slightly below average (Volume Ratio: 0.99), indicating a lack of strong conviction in the sell-off.
-
RSI (6): Dropped to 55.53, cooling off from near-overbought levels (>75) earlier in the week, suggesting a healthy short-term pullback.
-
MACD: The DIF (13.54) remains above the DEA (12.08) with a positive histogram (2.92), indicating the underlying bullish momentum is still intact despite the price dip.
Key Price Levels 🎯
-
Immediate Pivot: $626.36 (Recent Resistance). A close above could signal a resumption of the uptrend.
-
Primary Support: $567.36. A critical level that has held previously.
-
Strong Resistance: $643.99 (52-Week High). The key level to watch for a major breakout.
Valuation Perspective 💰
-
Forward P/E: 25.43x, which is above its historical average of 23.92x but within one standard deviation. This suggests the market is pricing in future growth, especially ahead of earnings.
-
P/S Ratio: 5.38x.
Analyst Targets 🎯
Analysts remain bullish. 26 institutions have an average price target of $653.28 (approx. +4.4% upside). Sentiment is strong with 8 Strong Buy, 17 Buy, and 4 Hold ratings.
Weekly Outlook 🔮
Expect consolidation between $626 - $640 ahead of the earnings report. A breakout above $644 (52-week high) could target the $653-$670 zone (aligning with analyst targets). A breakdown below the pivot ($626) may see a test of the $615-$600 support area.
Risk Disclaimer ⚠️
This analysis is for informational purposes only and not financial advice. Trading involves risk, including the potential loss of principal. Past performance is not indicative of future results. Always conduct your own research and consider your financial situation before investing.
For SG users only, Welcome to open a CBA today and enjoy access to a trading limit of up to SGD 20,000 with unlimited trading on SG, HK, and US stocks, as well as ETFs.
🎉Cash Boost Account Now Supports 35,000+ Stocks & ETFs – Greater Flexibility Now
Find out more here.
Complete your first Cash Boost Account trade with a trade amount of ≥ SGD1000* to get SGD 688 stock vouchers*! The trade can be executed using any payment type available under the Cash Boost Account: Cash, CPF, SRS, or CDP.
Other helpful links:
-
💰Join the TB Contra Telegram Group to Get $10 Trading Vouchers Now🎉
-
How to open a CBA. How to link your CDP account. Other FAQs on CBA. Cash Boost Account Website.
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.
